Video: Stopping Malaria Relapse – New Approaches For An Old Disease

22/01/2019 Editorial team

Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading ->

Single Dose Drug Effective For Recurrent Malaria, Trial Results Show

17/01/2019 Editorial team

A powerful new single-dose anti-malarial drug can significantly lower the risk of recurrent malaria from the Plasmodium vivax (P. vivax) species of the parasite, according to clinical trial results published today in the New England Journal of Medicine (NEJM). Continue reading ->

Health On The Margins As G20 Leaders Meet

30/11/2018 Health Policy Watch

As world leaders attending this year’s Group of 20 (G20) Summit face off on thorny issues of trade, migration and climate change – health was likely to remain on the margins of the maelstrom, observers said. The two-day Summit of the 20 largest global economies opened today in Buenos Aires, Argentina. Continue reading ->

Groups Target EU-Mercosur FTA To Advance Access To Health In Trade Deals

16/05/2018 Monika Ermert

AIDS activists, health activists and civil society organizations in Brazil and Argentina are pushing back against the negative effects of the planned free trade agreement between the Mercosur countries and the European Union. The EU-Mercosur negotiations might be the best chance as of now to advance an intellectual property agenda that is more favourable to access to health, says Pedro Villardi, coordinator on IP policy issues at the Associação Brasiliera Interdisciplinar de Aids Observatorio National de Politicas de Aids (ABIA). Continue reading ->

Patents Without Examination: A Bad Solution For The 21st Century

30/04/2018 Guest contributor

The Brazilian government's plan to deal with its patent backlog by making approvals without review is a recipe for disaster. It will move the backlog to the courts, with endless suits over duplicative and frivolous patents, write Arjun Jayadev and Dean Baker. Continue reading ->

Pharma, Nonprofits Collaborate On Affordable Hepatitis C Treatment In Latin America

06/03/2018 William New

The Drugs for Neglected Disease initiative (DNDi), a nonprofit research and development organisation, today announced a collaboration with pharmaceutical companies and other nonprofits to manufacture and supply a "new, more affordable" hepatitis C treatment in Latin America. Hepatitis C medicines have been renowned for their high prices worldwide. Continue reading ->

Leaked Letter Shows Pressure On Colombia Not To Issue Compulsory Licence For Glivec

06/02/2018 William New

A newly leaked 2016 letter from the CEO of Novartis to the president of Colombia, made available by Swiss group Public Eye, shows the level of concern the Swiss pharmaceutical company had over the effect of possible issuance of a compulsory licence for Novartis drug Glivec in the pivotal South American economy. Continue reading ->